Retina/Vitreous

Top Story

New questionnaire evaluates individual AMD risk

January 16, 2018

First patient enrolled in Zimura trial for Stargardt disease

January 16, 2018
The first patient has been enrolled in Ophthotech’s phase 2b trial of Zimura for the treatment of autosomal recessive Stargardt disease, the company announced in a…
Meeting NewsVideo

VIDEO: Advances give new relevance to retinal laser therapy

January 15, 2018
WAILEA, Hawaii — At Retina 2018, Victor Gonzalez, MD, discusses how technological advances have made laser treatment for retinal disease safe and efficacious.
Meeting News

Monday’s Hawaiian Eye 2018 speakers of the day named

January 15, 2018
WAILEA, Hawaii — Jack T. Holladay, MD, MSEE received the Hawaiian Eye Comprehensive Program’s Speaker of the Day for Monday. Attendees most likely voted for…
More Headlines »
CME

Medical Management of Glaucoma: Recent Approvals and Drugs Under Investigation

This activity is supported by educational grants from Aerie Pharmaceuticals, Inc.; Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people affected by the…
More »
Video
Meeting News

VIDEO: Gene therapy for retinal disease continues to march forward despite headwinds

January 15, 2018
More »
Resource Centers
American Academy of Optometry

American Academy of Optometry

Video
Meeting News

VIDEO: MicroPulse technology allows safe treatment of glaucoma, retina

November 22, 2017
More »
Advertisement
Advertisement